5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The India Respiratory Devices Market is segmented by Type (Diagnostic and Monitoring Devices, Therapeutic Devices, and Disposables)
The Indian respiratory devices market is expected to show a rapid growth due to the increasing prevalence of respiratory disorders, such as COPD, TB, asthma, and sleep apnea, along with technological advancements and increasing applications in-home care settings.
There is a high incidence rate of respiratory diseases in India. Rapid urbanization in the developing economy and a large amount of pollution contribute to this. According to the University of Washington’s Global Burden of Disease study, 2018 COPD was the second-highest cause of death in India killing 1 million (958,000) Indians in 2017. The awareness about these diseases and healthcare facilities has increased and the government is investing in mitigating respiratory ailments. There is also a rise in the ageing population, which is susceptible to such respiratory ailments. Thus, all these factors help in driving the respiratory devices market in India.
The healthcare industry in India has grown in recent years, and with the rise in the healthcare industry, there is disproportionate reliability over imports, where more than 70% of the medical devices are imported in industry sales in India.
As per the scope of the report, respiratory devices supply respiratory gas mechanically to the patients with impaired respiratory function. The respiratory gas is usually enriched with oxygen and conveyed into the lung with a positive pressure generated by the device. The respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It may also include a breathing apparatus used for resuscitation, by forcing oxygen into the lungs of a person who has undergone asphyxia. As per the scope of the report, respiratory inhalers, which are classified as combination products, have been considered as medical devices.
Report scope can be customized per your requirements. Click here.
The spirometer is a medical device, which is used to measure the proper functioning of the lungs, where the volume of air inhaled and exhaled from the lungs is measured after maximum inhalation by the patient. Spirometer helps in the identification of different respiratory diseases, such as bronchitis, chronic lung diseases that are obstructive, emphysema, asthma, and other breathing diseases, for screening in an occupational environment.
A spirometer is basically used to analyze the lung function before surgery and makes a prediction of the respiratory diseases.
The spirometers sub-segment has been fueled by the recent technological advancements in the field of spirometry that include the development of small portable spirometers and the increasing accuracy, acceptability, and reproducibility of assessments with immediate feedback to the technician.
Thus, the applications of spirometers in India make it easier for the patient to use this diagnostic devices especially for asthma, which is also increasingly being adopted in hospitals and home care.
To understand key trends, Download Sample Report
Some of the established companies for respiratory devices in India include AstraZeneca, Medtronic, Philips, Resmed, and GSK. These companies present in the market are found focusing on product innovations, expansions, finding new markets, or innovating their core competency to expand their individual market share.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Respiratory Disorders, such as COPD, TB, Asthma, and Sleep Apnea
4.2.2 Technological Advancements and Increasing Applications in Home care Settings
4.3 Market Restraints
4.3.1 High Cost of Devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type
5.1.1 By Diagnostic and Monitoring Devices
22.214.171.124 Sleep Test Devices
126.96.36.199 Peak Flow Meters
188.8.131.52 Pulse Oximeters
184.108.40.206 Other Diagnostic and Monitoring Devices
5.1.2 By Therapeutic Devices
220.127.116.11 CPAP Devices
18.104.22.168 BiPAP Devices
22.214.171.124 Oxygen Concentrators
126.96.36.199 Other Therapeutic Devices
5.1.3 By Disposables
188.8.131.52 Breathing Circuits
184.108.40.206 Other Disposables
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare)
6.1.2 Dragerwerk AG
6.1.3 Fisher & Paykel Healthcare Ltd
6.1.4 GE Healthcare
6.1.5 GlaxoSmithKline PLC
6.1.6 Koninklijke Philips NV
6.1.7 Medtronic PLC
6.1.8 ResMed Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments